Literature DB >> 24984825

The association between apolipoprotein M and insulin resistance varies with country of birth.

A A Memon1, L Bennet2, B Zöller3, X Wang3, K Palmér3, B Dahlbäck4, J Sundquist5, K Sundquist5.   

Abstract

BACKGROUND AND AIMS: Risk of type 2 diabetes mellitus (T2DM) differs according to ethnicity. Levels of apolipoprotein M (ApoM) have been shown to be decreased in T2DM. However, its role in different ethnicities is not known. We examined the differences in plasma ApoM levels in Swedish residents born in Iraq (Iraqis) and Sweden (Swedes) in relation to T2DM and insulin resistance (IR). METHODS AND
RESULTS: Iraqis and Swedes, aged 45-65 years residing in Rosengård area of Malmö were randomly selected from census records and underwent an oral glucose tolerance test. Plasma levels of ApoM were quantified in 162 participants (Iraqis, n = 91; Swedes, n = 71) by a sandwich ELISA method. Age-, sex-, and body mass index (BMI) adjusted plasma ApoM levels differed by country of birth, with Swedes having 18% higher levels compared to Iraqis (p = 0.001). ApoM levels (mean ± SD) were significantly decreased in Swedes with T2DM (0.73 ± 0.18) compared to those with normal glucose tolerance (NGT) (0.89 ± 0.24; p = 0.03). By contrast, no significant difference in ApoM levels was found between Iraqis with T2DM (0.70 ± 0.17) and those with NGT (0.73 ± 0.13; p = 0.41). In multivariate linear regression analysis with an interaction term between IR and country of birth, low ApoM levels remained significantly associated with IR in Swedes (p = 0.008), independently of age, sex, BMI, family history of diabetes, HDL, LDL, and triglycerides, but not in Iraqis (p = 0.35).
CONCLUSION: Our results show that ApoM levels differ according to country of birth and are associated with IR and T2DM only in Swedes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apolipoprotein M; Ethnicity; Insulin resistance; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 24984825     DOI: 10.1016/j.numecd.2014.05.007

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  4 in total

Review 1.  Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.

Authors:  Yelena Drexler; Judith Molina; Alla Mitrofanova; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 14.978

2.  Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL.

Authors:  Mustafa Yalcinkaya; Arnold von Eckardstein
Journal:  Diabetes       Date:  2020-05       Impact factor: 9.461

3.  Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels.

Authors:  Yaprak Engin-Üstün; Emel Kıyak Çağlayan; Ayşe Yeşim Göçmen; Muhammed Fevzi Polat
Journal:  J Menopausal Med       Date:  2016-08-30

4.  Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate.

Authors:  Tamaki Kobayashi; Makoto Kurano; Mai Nanya; Tomo Shimizu; Ryunosuke Ohkawa; Minoru Tozuka; Yutaka Yatomi
Journal:  J Atheroscler Thromb       Date:  2021-01-29       Impact factor: 4.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.